Related Experiment Video
Updated: Aug 11, 2026

07:52
Simultaneous Electrophysiological Recording and Micro-injections of Inhibitory Agents in the Rodent Brain
Published on: July 7, 2015
Repeated intracerebral microinjections: efficacy in studying brain functions
Ra Vetrivelan1, Hruda Nanda Mallick, Velayudhan Mohan Kumar
1Department of Physiology, All India Institute of Medical Sciences, New Delhi - 110 029.
Indian Journal of Physiology and Pharmacology
|May 24, 2005
Summary
This study found that repeated brain injections can alter drug effects. Researchers recommend using only one drug injection per animal, but vehicle injections are acceptable for further testing.
Area of Science:
- Neuroscience
- Pharmacology
- Animal Models
Background:
- Intracranial injections are vital for brain research.
- Typically, only one injection is administered per animal to avoid confounding results.
- The medial preoptic area is a key brain region involved in thermoregulation.
Purpose of the Study:
- To assess the impact of repeated injections on body temperature data.
- To evaluate the effects of methoxamine and artificial cerebrospinal fluid (ACSF) administered twice.
- To determine if a second injection compromises data quality.
Main Methods:
- Animals received initial injections of methoxamine or ACSF into the medial preoptic area.
- A second injection of the same substance was administered.
- Body temperature was monitored to quantify the effects of each injection.
Main Results:
- A quantitative decrease in body temperature effects was observed after the second methoxamine injection.
- No significant change in body temperature effects was found after the second ACSF injection.
- Data quality was not compromised by a second administration of the vehicle (ACSF).
Conclusions:
- The findings support the existing recommendation for a single drug injection per brain site.
- Vehicle injections can be safely administered as a second procedure without affecting data integrity.
- This research refines protocols for brain injection studies, ensuring reliable neuropharmacological data.

